Planning Grants for Institutional Clinical and Translational Science Awards
机构临床和转化科学奖规划拨款
基本信息
- 批准号:7215007
- 负责人:
- 金额:$ 22.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-22 至 2007-09-21
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The NIH effort to Re-engineer the Clinical Research Enterprise provides an opportunity for academic medical centers to reorganize their clinical research infrastructures into an integrated institutional home. The overarching goal is to enhance the quality and efficiency of clinical and translational research and to support the training of new clinical and translational science investigators. The purpose of this proposal is to plan activities to design the University of Maryland (UM) Clinical and Translational Science Research Center (CTSRC). These activities will include developing plans for the content, governance, administration, and evaluation of the Center. In addition, the planning process will include effecting the cultural changes at UMB needed to launch the concepts of team science and the discrete discipline of clinical and translational science. The University of Maryland Baltimore has many of the elements of a CTSRC, including a committed clinician scientist and administrative team to provide leadership as well as collaborating institutions to ensure multidisciplinary participation. These institutions include the UM Schools of Medicine, Dentistry, Pharmacy, Nursing, Social Work, and Law as well as the Graduate School. In addition, UM has both a K30 Curriculum Development Award with a Masters Degree in Clinical Research and a Roadmap K12 Award for Multidisciplinary Clinical Research Career Development. We plan to build a T-32 like program in clinical and translational research. Our planning process will be built around the work of 4 committees: an Executive Committee, Training/Career Development/Pilot Studies Committee, Resources and Services Committee, and an internal advisory committee. The process will include a needs assessment, planning retreat, and site visits to other funded clinical and translational science awardees. The planning grant will support efforts to identify components of the CTSRC particularly in the areas of novel methodologies, bioinformatics, study design and biostatistics, regulatory support, participant and clinical interactions, community engagement, and training and career development.
描述(由申请人提供):NIH重新设计临床研究企业的努力为学术医疗中心提供了一个机会,将其临床研究基础设施重组为一个综合的机构。总体目标是提高临床和转化研究的质量和效率,并支持培训新的临床和转化科学研究人员。本提案的目的是规划活动,设计马里兰大学(UM)临床和转化科学研究中心(CTSRC)。这些活动将包括为中心的内容、治理、管理和评估制定计划。此外,规划过程将包括影响UMB的文化变革,以启动团队科学和临床和转化科学的离散学科的概念。马里兰大学巴尔的摩分校拥有CTSRC的许多要素,包括一个忠诚的临床医生、科学家和管理团队,以提供领导,以及合作机构,以确保多学科参与。这些机构包括澳大医学院、牙科学院、药学院、护理学院、社会工作学院、法学院以及研究生院。此外,澳大还获得了K30临床研究硕士课程发展奖和K12多学科临床研究职业发展路线图奖。我们计划在临床和转化研究中建立一个类似T-32的项目。我们的规划过程将围绕四个委员会的工作展开:执行委员会、培训/职业发展/试点研究委员会、资源和服务委员会以及内部咨询委员会。这一过程将包括需求评估、计划撤退以及对其他资助的临床和转化科学获奖者的实地考察。规划拨款将支持确定CTSRC组成部分的努力,特别是在新方法、生物信息学、研究设计和生物统计学、监管支持、参与者和临床互动、社区参与、培训和职业发展等领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carol Tacket其他文献
Carol Tacket的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carol Tacket', 18)}}的其他基金
CLINICAL TRIAL: PHASE I STUDY OF INTRANASAL NORWALK VLP VACCINE WITH ADJUVANT &
临床试验:鼻内 NORWALK VLP 疫苗与佐剂的 I 期研究
- 批准号:
7951170 - 财政年份:2009
- 资助金额:
$ 22.28万 - 项目类别:
CLINICAL TRIAL: PHASE I PRIME-BOOST STUDY OF VI POLYSACCHARIDE TYPHOID VACCINE A
临床试验:VI多糖伤寒疫苗A的I期初免-加强研究
- 批准号:
7951156 - 财政年份:2009
- 资助金额:
$ 22.28万 - 项目类别:
CLINICAL TRIAL: PHASE I STUDY OF INTRANASAL NORWALK VLP VACCINE WITH ADJUVANT &
临床试验:鼻内 NORWALK VLP 疫苗与佐剂的 I 期研究
- 批准号:
7718091 - 财政年份:2008
- 资助金额:
$ 22.28万 - 项目类别:
PHASE I RANDOMIZED, DOUBLE-BLIND HETEROLOGOUS PRIME BOOST STUDY OF THE SAFETY &9
I 期随机、双盲异质素增强安全性研究
- 批准号:
7608159 - 财政年份:2007
- 资助金额:
$ 22.28万 - 项目类别:
PLANNING GRANTS FOR INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDS
规划机构临床和转化科学奖资助
- 批准号:
7682650 - 财政年份:2006
- 资助金额:
$ 22.28万 - 项目类别:
PRIME-BOOST STUDY OF VI TYPHOID VACCINE AND ORAL TYPHOID VACCINE STRAIN CVD 909
VI 伤寒疫苗和口服伤寒疫苗 CVD 909 株的初免-加强研究
- 批准号:
7376976 - 财政年份:2006
- 资助金额:
$ 22.28万 - 项目类别:
CHOLERA 47000: USE OF IN VIVO EXPRESSION TECHNOLOGY TO IDENTIFY VIRULENCE FACTO
霍乱 47000:利用体内表达技术鉴定毒力因子
- 批准号:
7203297 - 财政年份:2005
- 资助金额:
$ 22.28万 - 项目类别:
Safety/Pharmacokinetics of caStx2 in Health
caStx2 在健康中的安全性/药代动力学
- 批准号:
6981328 - 财政年份:2004
- 资助金额:
$ 22.28万 - 项目类别:
Plant Based Microbicides and Vaccines to Prevent STIs
预防性传播感染的植物杀微生物剂和疫苗
- 批准号:
6866243 - 财政年份:2004
- 资助金额:
$ 22.28万 - 项目类别:
MUCOSAL IMMUNITY AND ORAL TOLERANCE--INNATE IMMUNITY
粘膜免疫和口腔耐受性——先天免疫
- 批准号:
6374619 - 财政年份:2000
- 资助金额:
$ 22.28万 - 项目类别: